Analysis of Death receptor 5 and caspase-8 expression in primary and metastatic head and neck squamous cell carcinoma and their prognostic impact

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Elrod, Heath A ^a   Fan, Songqing ^a   Muller, Susan ^a   Chen, Georgia Z ^a   Pan, Lin ^a   Tighiouart, Mourad ^a   Shin, Dong M ^a   Khuri, Fadlo R ^a   Sun, Shi Yong ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; DEATH RECEPTOR 5; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ADULT; ARTICLE; CANCER GRADING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIMARY TUMOR; PROGNOSIS; PROTEIN EXPRESSION; SMOKING; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; SURVIVAL RATE;

CARCINOMA, SQUAMOUS CELL; CASPASE 8; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; SURVIVAL RATE;

EID: 77957871112     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012178     Document Type: Article

References (52)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
2. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
3. Seiwert TY, Cohen EE (2005) State-of-the-art management of locally advanced head and neck cancer. Br J Cancer 92: 1341-1348.
4. Ashkenazi A (2008) Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev 19: 325-331.
5. Koornstra JJ, Jalving M, Rijcken FE, Westra J, Zwart N, et al. (2005) Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: potential targets for apoptosis induction. Eur J Cancer 41: 1195-1202.
6. van Geelen CM, Westra JL, de Vries EG, Boersma-van Ek W, Zwart N, et al. (2006) Prognostic significance of tumor necrosis factor-related apoptosisinducing ligand and its receptors in adjuvantly treated stage III colon cancer patients. J Clin Oncol 24: 4998-5004.
7. Spierings DC, de Vries EG, Timens W, Groen HJ, Boezen HM, et al. (2003) Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors. Clin Cancer Res 9: 3397-3405.
8. Reesink-Peters N, Hougardy BM, van den Heuvel FA, Ten Hoor KA, Hollema H, et al. (2005) Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study. Gynecol Oncol 96: 705-713.
9. Cooper WA, Kohonen-Corish MR, Zhuang L, McCaughan B, Kennedy C, et al. (2008) Role and prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand death receptor DR5 in nonsmall-cell lung cancer and precursor lesions. Cancer 113: 135-142.
10. Grosse-Wilde A, Voloshanenko O, Bailey SL, Longton GM, Schaefer U, et al. (2008) TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development. J Clin Invest 118: 100-110.
11. Bellail AC, Qi L, Mulligan P, Chhabra V, Hao C (2009) TRAIL agonists on clinical trials for cancer therapy: the promises and the challenges. Rev Recent Clin Trials 4: 34-41.
12. Hengartner MO (2000) The biochemistry of apoptosis. Nature 407: 770-776.
13. Heijink DM, Kleibeuker JH, Jalving M, Boersma-van Ek W, Koornstra JJ, et al. (2007) Independent induction of caspase-8 and cFLIP expression during colorectal carcinogenesis in sporadic and HNPCC adenomas and carcinomas. Cell Oncol 29: 409-419.
14. Xu B, Zhou ZG, Li Y, Wang L, Yang L, et al. (2008) Clinicopathological significance of caspase-8 and caspase-10 expression in rectal cancer. Oncology 74: 229-236.
15. Yoo NJ, Kim HS, Kim SY, Park WS, Kim SH, et al. (2002) Stomach cancer highly expresses both initiator and effector caspases; an immunohistochemical study. APMIS 110: 825-832.
16. Virkajarvi N, Paakko P, Soini Y (1998) Apoptotic index and apoptosis influencing proteins bcl-2, mcl-1, bax and caspases 3, 6 and 8 in pancreatic carcinoma. Histopathology 33: 432-439.
17. Vakkala M, Paakko P, Soini Y (1999) Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion. Br J Cancer 81: 592-599.
18. Fulda S, Poremba C, Berwanger B, Hacker S, Eilers M, et al. (2006) Loss of caspase-8 expression does not correlate with MYCN amplification, aggressive disease, or prognosis in neuroblastoma. Cancer Res 66: 10016-10023.
19. Hopkins-Donaldson S, Ziegler A, Kurtz S, Bigosch C, Kandioler D, et al. (2003) Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation. Cell Death Differ 10: 356-364.
20. Shivapurkar N, Toyooka S, Eby MT, Huang CX, Sathyanarayana UG, et al. (2002) Differential inactivation of caspase-8 in lung cancers. Cancer Biol Ther 1: 65-69.
21. Harada K, Toyooka S, Shivapurkar N, Maitra A, Reddy JL, et al. (2002) Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. Cancer Res 62: 5897-5901.
22. Zuzak TJ, Steinhoff DF, Sutton LN, Phillips PC, Eggert A, et al. (2002) Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour/medulloblastoma. Eur J Cancer 38: 83-91.
23. Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, et al. (2000) Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 6: 529-535.
24. Soung YH, Lee JW, Kim SY, Sung YJ, Park WS, et al. (2005) Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225_1226delTG in hepatocellular carcinomas. Oncogene 24: 141-147.
25. Soung YH, Lee JW, Kim SY, Jang J, Park YG, et al. (2005) CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res 65: 815-821.
26. Stupack DG, Teitz T, Potter MD, Mikolon D, Houghton PJ, et al. (2006) Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature 439: 95-99.
27. Barbero S, Mielgo A, Torres V, Teitz T, Shields DJ, et al. (2009) Caspase-8 association with the focal adhesion complex promotes tumor cell migration and metastasis. Cancer Res 69: 3755-3763.
28. Barbero S, Barila D, Mielgo A, Stagni V, Clair K, et al. (2008) Identification of a critical tyrosine residue in caspase 8 that promotes cell migration. J Biol Chem 283: 13031-13034.
29. Pingoud-Meier C, Lang D, Janss AJ, Rorke LB, Phillips PC, et al. (2003) Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma. Clin Cancer Res 9: 6401-6409.
30. Zhang X, Hunt JL, Landsittel DP, Muller S, Adler-Storthz K, et al. (2004) Correlation of protease-activated receptor-1 with differentiation markers in squamous cell carcinoma of the head and neck and its implication in lymph node metastasis. Clin Cancer Res 10: 8451-8459.
31. Muller S, Su L, Tighiouart M, Saba N, Zhang H, et al. (2008) Distinctive Ecadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation. Cancer 113: 97-107.
32. Wajant H (2006) CD95L/FasL and TRAIL in tumour surveillance and cancer therapy. Cancer Treat Res 130: 141-165.
33. Wajant H, Pfizenmaier K, Scheurich P (2002) TNF-related apoptosis inducing ligand (TRAIL) and its receptors in tumor surveillance and cancer therapy. Apoptosis 7: 449-459.
34. Takeda K, Hayakawa Y, Smyth MJ, Kayagaki N, Yamaguchi N, et al. (2001) Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 7: 94-100.
35. Zhuang L, Lee CS, Scolyer RA, McCarthy SW, Zhang XD, et al. (2006) Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor-related apoptosis-inducing ligand. Hum Pathol 37: 1286-1294.
36. Laguinge LM, Samara RN, Wang W, El-Deiry WS, Corner G, et al. (2008) DR5 receptor mediates anoikis in human colorectal carcinoma cell lines. Cancer Res 68: 909-917.
37. Samara RN, Laguinge LM, Jessup JM (2007) Carcinoembryonic antigen inhibits anoikis in colorectal carcinoma cells by interfering with TRAIL-R2 (DR5) signaling. Cancer Res 67: 4774-4782.
38. Trauzold A, Siegmund D, Schniewind B, Sipos B, Egberts J, et al. (2006) TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma. Oncogene 25: 7434-7439.
39. Lu LM, Zavitz CC, Chen B, Kianpour S, Wan Y, et al. (2007) Cigarette smoke impairs NK cell-dependent tumor immune surveillance. J Immunol 178: 936-943.
40. Xu L, Deng X (2006) Protein kinase Ciota promotes nicotine-induced migration and invasion of cancer cells via phosphorylation of micro- and m-calpains. J Biol Chem 281: 4457-4466.
41. Xu L, Deng X (2004) Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone induces phosphorylation of mu- and m-calpain in association with increased secretion, cell migration, and invasion. J Biol Chem 279: 53683-53690.
42. Murin S, Pinkerton KE, Hubbard NE, Erickson K (2004) The effect of cigarette smoke exposure on pulmonary metastatic disease in a murine model of metastatic breast cancer. Chest 125: 1467-1471.
43. Nagaraj NS, Zacharias W (2007) Cigarette smoke condensate increases cathepsin-mediated invasiveness of oral carcinoma cells. Toxicol Lett 170: 134-145.
44. Duiker EW, van der Zee AG, de Graeff P, Boersma-van EkW, Hollema H, et al. The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer. Gynecol Oncol 116: 549-555.
45. Maduro JH, Noordhuis MG, ten Hoor KA, Pras E, Arts HJ, et al. (2009) The prognostic value of TRAIL and its death receptors in cervical cancer. Int J Radiat Oncol Biol Phys 75: 203-211.
46. Ganten TM, Sykora J, Koschny R, Batke E, Aulmann S, et al. (2009) Prognostic significance of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in patients with breast cancer. J Mol Med 87: 995-1007.
47. Frisch SM (2008) Caspase-8: fly or die. Cancer Res 68: 4491-4493.
48. Almasan A, Ashkenazi A (2003) Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev 14: 337-348.
49. Senft J, Helfer B, Frisch SM (2007) Caspase-8 interacts with the p85 subunit of phosphatidylinositol 3-kinase to regulate cell adhesion and motility. Cancer Res 67: 11505-11509.
50. Helfer B, Boswell BC, Finlay D, Cipres A, Vuori K, et al. (2006) Caspase-8 promotes cell motility and calpain activity under nonapoptotic conditions. Cancer Res 66: 4273-4278.
51. Finlay D, Vuori K (2007) Novel noncatalytic role for caspase-8 in promoting SRC-mediated adhesion and Erk signaling in neuroblastoma cells. Cancer Res 67: 11704-11711.
52. Wiezorek J, Holland P, Graves J (2010) Death receptor agonists as a targeted therapy for cancer. Clin Cancer Res 16: 1701-1708.